SEARCH

SEARCH BY CITATION

References

  • 1
    Freeman GJ, Casasnovas JM, Umetsu DT & DeKruyff RH (2010) TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunol Rev 235, 172189.
  • 2
    McIntire JJ, Umetsu DT & DeKruyff RH (2004) TIM-1, a novel allergy and asthma susceptibility gene. Springer Semin Immunopathol 25, 335348.
  • 3
    Chakravarti S, Sabatos CA, Xiao S, Illes Z, Cha EK, Sobel RA, Zheng XX, Strom TB & Kuchroo VK (2005) Tim-2 regulates T helper type 2 responses and autoimmunity. J Exp Med 202, 437444.
  • 4
    Kawamoto T, Abe Y, Ito J, Makino F, Kojima Y, Usui Y, Ma J, Morimoto S, Yagita H, Okumura K et al. (2011) Anti-T cell immunoglobulin and mucin domain-2 monoclonal antibody exacerbates collagen-induced arthritis by stimulating B cells. Arthritis Res Ther 13, R47.
  • 5
    Recalcati S, Invernizzi P, Arosio P & Cairo G (2008) New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. J Autoimmun 30, 8489.
  • 6
    Chen TT, Li L, Chung DH, Allen CD, Torti SV, Torti FM, Cyster JG, Chen CY, Brodsky FM, Niemi EC et al. (2005) TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis. J Exp Med 202, 955965.
  • 7
    Todorich B, Zhang X, Slagle-Webb B, Seaman WE & Connor JR (2008) Tim-2 is the receptor for H-ferritin on oligodendrocytes. J Neurochem 107, 14951505.
  • 8
    Han J, Seaman WE, Di X, Wang W, Willingham M, Torti FM & Torti SV (2011) Iron uptake mediated by binding of H-ferritin to the TIM-2 receptor in mouse cells. PLoS ONE 6, e23800.
  • 9
    Rennert PD, Ichimura T, Sizing ID, Bailly V, Li Z, Rennard R, McCoon P, Pablo L, Miklasz S, Tarilonte L et al. (2006) T cell, Ig domain, mucin domain-2 gene-deficient mice reveal a novel mechanism for the regulation of Th2 immune responses and airway inflammation. J Immunol 177, 43114321.
  • 10
    Fukushima A, Sumi T, Fukuda K, Kumagai N, Nishida T, Okumura K, Akiba H, Yagita H & Ueno H (2007) T-cell Ig and mucin domain-containing protein (Tim)-2 regulates murine allergic conjunctivitis during the effector phase. Immunol Lett 110, 133138.
  • 11
    Scheller J, Chalaris A, Garbers C & Rose-John S (2011a) ADAM17: a molecular switch controlling inflammatory and regenerative responses. Trends Immunol 32, 380387.
  • 12
    Edwards DR, Handsley MM & Pennington CJ (2008) The ADAM metalloproteinases. Mol Aspects Med 29, 258289.
  • 13
    Garbers C, Jänner N, Chalaris A, Moss ML, Floss DM, Meyer D, Koch-Nolte F, Rose-John S & Scheller J (2011) Species specificity of ADAM10 and ADAM7 in IL-6 transsignaling and novel role of ADAM10 in inducible IL-6R shedding. J Biol Chem 286, 1480414811.
  • 14
    Le Gall SM, Bobé P, Reiss K, Horiuchi K, Niu XD, Lundell D, Gibb DR, Conrad D, Saftig P & Blobel CP (2009) ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha L-selectin, and tumor necrosis factor alpha. Mol Biol Cell 20, 17851794.
  • 15
    Matthews V, Schuster B, Schütze S, Bußmeyer I, Ludwig A, Hundhausen C, Sadowski T, Saftig P, Hartmann D, Kallen K-J et al. (2003) Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE). J Biol Chem 278, 3882938839.
  • 16
    Ludwig A, Hundhausen C, Lambert MH, Broadway N, Andrews RC, Bickett DM, Leesnitzer MA & Becherer JD (2005) Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules. Comb Chem High Throughput Screen 8, 161171.
  • 17
    Moss ML, Bomar M, Liu Q, Sage H, Dempsey P, Lenhart PM, Gillispie PA, Stoeck A, Wildeboer D, Bartsch JW et al. (2007) The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events. J Biol Chem 282, 3571235721.
  • 18
    Arribas J, Coodly L, Vollmer P, Kishimoto TK, Rose-John S & Massague J (1996) Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. J Biol Chem 271, 1137611382.
  • 19
    Caescu CI, Jeschke GR & Turk BE (2009) Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10. Biochem J 424, 7988.
  • 20
    Müllberg J, Oberthur W, Lottspeich F, Mehl E, Dittrich E, Graeve L, Heinrich PC & Rose-John S (1994) The soluble human IL-6 receptor Mutational characterization of the proteolytic cleavage site. J Immunol 152, 49584968.
  • 21
    Baran P, Nitz R, Grötzinger J, Scheller J & Garbers C (2013) Minimal interleukin (IL-)6 receptor stalk composition for IL-6R shedding and IL-6 classic signaling. J Biol Chem 288, 1475614768.
  • 22
    Stefanini S, Cavallo S, Wang CQ, Tataseo P, Vecchini P, Giartosio A & Chiancone E (1996) Thermal stability of horse spleen apoferritin and human recombinant H apoferritin. Arch Biochem Biophys 325, 5864.
  • 23
    Jostock T, Müllberg J, Özbek S, Atreya R, Blinn G, Voltz N, Fischer M, Neurath MF & Rose-John S (2001) Soluble gp130 is the natural inhibitor of soluble IL-6R transsignaling responses. Eur J Biochem 268, 160167.
  • 24
    Kahn J, Walcheck B, Migaki GI, Jutila MA & Kishimoto TK (1998) Calmodulin regulates L-selectin adhesion molecule expression and function through a protease-dependent mechanism. Cell 92, 809818.
  • 25
    Canobbio I, Catricala S, Balduini C & Torti M (2011) Calmodulin regulates the non-amyloidogenic metabolism of amyloid precursor protein in platelets. Biochim Biophys Acta 1813, 500506.
  • 26
    Mou P, Zeng Z, Li Q, Liu X, Xin X, Wannemacher KM, Ruan C, Li R, Brass LF & Zhu L (2013) Identification of a calmodulin-binding domain in Sema4D that regulates its exodomain shedding in platelets. Blood 121, 42214230.
  • 27
    Gifford JL, Ishida H & Vogel HJ (2012) Structural insights into calmodulin-regulated L-selectin ectodomain shedding. J Biol Chem 287, 2651326527.
  • 28
    Müllberg J, Schooltink H, Stoyan T, Gunther M, Graeve L, Buse G, Mackiewicz A, Heinrich PC & Rose-John S (1993) The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol 23, 473480.
  • 29
    Mullberg J, Schooltink H, Stoyan T, Heinrich PC & Rose-John S (1992) Protein kinase C activity is rate limiting for shedding of the interleukin-6 receptor. Biochem Biophys Res Commun 189, 794800.
  • 30
    Maretzky T, Reiss K, Ludwig A, Buchholz J, Scholz F, Proksch E, de Strooper B, Hartmann D & Saftig P (2005) ADAM10 mediates E-cadherin shedding and regulates epithelial cell–cell adhesion, migration, and beta-catenin translocation. Proc Natl Acad Sci USA 102, 91829187.
  • 31
    Reiss K, Maretzky T, Ludwig A, Tousseyn T, de Strooper B, Hartmann D & Saftig P (2005) ADAM10 cleavage of N-cadherin and regulation of cell–cell adhesion and beta-catenin nuclear signalling. EMBO J 24, 742752.
  • 32
    Lorenzen I, Lokau J, Dusterhoft S, Trad A, Garbers C, Scheller J, Rose-John S & Grotzinger J (2012) The membrane-proximal domain of A Disintegrin and Metalloprotease 17 (ADAM17) is responsible for recognition of the interleukin-6 receptor and interleukin-1 receptor II. FEBS Lett 586, 10931100.
  • 33
    Hundhausen C, Misztela D, Berkhout TA, Broadway N, Saftig P, Hartmann D, Fahrenholz F, Postina R, Matthews V, Kallen K-J et al. (2003) The disintegrin-like metalloproteinase ADAM 10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell–cell adhesion. Blood 102, 11861195.
  • 34
    Scheller J, Chalaris A, Schmidt-Arras D & Rose-John S (2011b) The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 1813, 878888.
  • 35
    Alexopoulou L, Kranidioti K, Xanthoulea S, Denis M, Kotanidou A, Douni E, Blackshear PJ, Kontoyiannis DL & Kollias G (2006) Transmembrane TNF protects mutant mice against intracellular bacterial infections, chronic inflammation and autoimmunity. Eur J Immunol 36, 27682780.
  • 36
    Evstatiev R & Gasche C (2012) Iron sensing and signalling. Gut 61, 933952.
  • 37
    Jostock T, Blinn G, Renné C, Kallen K-J, Rose-John S & Müllberg J (1999) Immunoadhesins of IL-6 and Hyper-IL-6. J Immunol Methods 223, 171183.
  • 38
    Tenhumberg S, Schuster B, Zhu L, Kovaleva M, Scheller J, Kallen KJ & Rose-John S (2006) gp130 dimerization in the absence of ligand: preformed cytokine receptor complexes. Biochem Biophys Res Commun 346, 649657.
  • 39
    Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S et al. (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385, 729733.
  • 40
    Hartmann D, De Strooper B, Serneels L, Craessaerts K, Herreman A, Annaert W, Umans L, Lubke T, Lena IA, von Figura K et al. (2002) The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts. Hum Mol Genet 11, 26152624.
  • 41
    Reiss K, Maretzky T, Haas IG, Schulte M, Ludwig A, Frank M & Saftig P (2006) Regulated ADAM10-dependent ectodomain shedding of gamma-protocadherin C3 modulates cell–cell adhesion. J Biol Chem 281, 9851006.
  • 42
    Schwarz N, Fliegert R, Adriouch S, Seman M, Guse AH, Haag F & Koch-Nolte F (2009) Activation of the P2X7 ion channel by soluble and covalently bound ligands. Purinergic Signal 5, 139149.